Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up).
Silverberg JI, Bunick CG, Hong HC, Mendes-Bastos P, Stein Gold L, Costanzo A, Ibrahim N, Sancho C, Wu X, Han Y, Levy G, Altman K, Calimlim B, Eyerich K.
Br J Dermatol. 2024 Dec 23;192(1):36-45. doi: 10.1093/bjd/ljae404.
PMID:39438067
The role of microRNAs in atopic dermatitis.
Khosrojerdi M, Azad FJ, Yadegari Y, Ahanchian H, Azimian A.
Ayala F, Fabbrocini G, Bacchilega R, Berardesca E, Caraffini S, Corazza M, Flori ML, Francalanci S, Guarrera M, Lisi P, Santucci B, Schena D, Suppa F, Valsecchi R, Vincenzi C, Balato N; Gruppo Italiano di Ricerca sulle Dermatiti da Contatto e Ambientali della Società Italiana di Dermatologia e Venereologia.